Literature DB >> 7845600

Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers.

P Pakzaban1, O Isacson.   

Abstract

Selective replacement of degenerated neurons in the adult brain with allogeneic fetal neuroblasts is a promising therapeutic modality for human neurodegenerative diseases, but is confounded with practical and potential ethical problems. To evaluate the potential of xenogeneic donors as a cell source for neural transplantation, we have critically examined the available experimental evidence in animal models pertaining to the survival, integration and function of xenogeneic fetal neuroblasts in the host brain. A statistical meta-analysis across multiple studies revealed that immunologically-related transplantation parameters (immunosuppression and donor-host phylogenetic distance) were the main determinants of neural xenograft survival. The immunological basis for xenograft rejection is reviewed in the context of novel immunoprotection strategies designed to enhance xenograft survival. Furthermore, the evidence for behavioral recovery based on anatomical and functional integration of neural xenografts in the host brain is examined with an awareness of developmental considerations. It is concluded that neural xenotransplantation offers a unique opportunity for effective neuronal replacement with significant potential for clinical use.

Entities:  

Mesh:

Year:  1994        PMID: 7845600     DOI: 10.1016/0306-4522(94)90338-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  8 in total

1.  A role for complement in the rejection of porcine ventral mesencephalic xenografts in a rat model of Parkinson's disease.

Authors:  R A Barker; E Ratcliffe; M McLaughlin; A Richards; S B Dunnett
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

2.  Neonatal desensitization allows long-term survival of neural xenotransplants without immunosuppression.

Authors:  Claire M Kelly; Sophie V Precious; Caroline Scherf; Richard Penketh; Nazar N Amso; Alysia Battersby; Nicholas D Allen; Stephen B Dunnett; Anne E Rosser
Journal:  Nat Methods       Date:  2009-03-08       Impact factor: 28.547

Review 3.  Immune problems in central nervous system cell therapy.

Authors:  Roger A Barker; Håkan Widner
Journal:  NeuroRx       Date:  2004-10

4.  Porcine encephalomyocarditis virus persists in pig myocardium and infects human myocardial cells.

Authors:  L A Brewer; H C Lwamba; M P Murtaugh; A C Palmenberg; C Brown; M K Njenga
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

5.  A wild-type porcine encephalomyocarditis virus containing a short poly(C) tract is pathogenic to mice, pigs, and cynomolgus macaques.

Authors:  Rebecca LaRue; Suzanne Myers; Laurie Brewer; Daniel P Shaw; Corrie Brown; Bruce S Seal; M Kariuki Njenga
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Gene therapy for experimental brain tumors using a xenogenic cell line engineered to secrete hIL-2.

Authors:  Maciej S Lesniak; Betty M Tyler; Drew M Pardoll; Henry Brem
Journal:  J Neurooncol       Date:  2003 Aug-Sep       Impact factor: 4.130

7.  Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.

Authors:  Virginie Bonnamain; Isabelle Neveu; Philippe Naveilhan
Journal:  Front Cell Neurosci       Date:  2012-04-11       Impact factor: 5.505

8.  hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation.

Authors:  Andreas Heuer; Agnete Kirkeby; Ulrich Pfisterer; Marie E Jönsson; Malin Parmar
Journal:  Exp Neurol       Date:  2016-05-25       Impact factor: 5.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.